Literature DB >> 17949500

Neuroendocrine (Merkel cell) carcinoma of the retroperitoneum with no identifiable primary site.

Van Boghossian1, Ira D Owen, Balakrishna Nuli, Philip Q Xiao.   

Abstract

BACKGROUND: Neuroendocrine carcinoma is an aggressive neoplasm that mainly affects elderly Caucasians and typically arises in sun-exposed areas of the skin. The disease is rather rare and only a relatively few cases present with no apparent primary lesion. CASE
PRESENTATION: We report a case of an 81-year-old Caucasian male with neuroendocrine carcinoma, which initially presented as a large retroperitoneal mass. Pathological and immunohistochemical analysis of the transabdominal CT-guided biopsy specimen revealed tissue consistent with neuroendocrine carcinoma. The patient underwent exploratory laparotomy and the mass was successfully excised along with an associated mesenteric lymph node. DISCUSSION: There are currently two possible explanations for what occurred in our patient. First, the retroperitoneal mass could be a massively enlarged lymph node where precursor cells became neoplastic. This would be consistent with a presumptive diagnosis of primary nodal disease. Alternatively, an initial skin lesion could have spontaneously regressed and the retroperitoneal mass represents a single site of metastasis. Since Merkel cell precursors have never been identified within lymph nodes, the latter theory seems more befitting. Moreover, metastasis to the retroperitoneal lymph nodes has been reported as relatively common when compared to other sites such as liver, bone, brain and skin.
CONCLUSION: Wide local excision of the primary tumor is the surgical treatment of choice for localized disease. We propose that further studies are needed to elucidate the true efficacy of chemotherapy in conventional as well as unconventional patients with neuroendocrine carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17949500      PMCID: PMC2117014          DOI: 10.1186/1477-7819-5-117

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  20 in total

Review 1.  Merkel cell carcinoma of the skin.

Authors:  P T Tai; E Yu; J Tonita; J Gilchrist
Journal:  J Cutan Med Surg       Date:  2000-10       Impact factor: 2.092

2.  Nodal neuroendocrine (Merkel cell) carcinoma without an identifiable primary tumor.

Authors:  Hiroko Kuwabara; Hiroshi Mori; Hirotsugu Uda; Kiyozumi Takei; Yoshichika Ishibashi; Naotomo Takatani
Journal:  Acta Cytol       Date:  2003 May-Jun       Impact factor: 2.319

3.  Neuroendocrine (Merkel cell) carcinoma in regional lymph nodes without primary site.

Authors:  Eldad Silberstein; Michael Koretz; Emanuela Cagnano; Leonid Katchko; Lior Rosenberg
Journal:  Isr Med Assoc J       Date:  2003-06       Impact factor: 0.892

4.  Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population.

Authors:  T Y Chuang; W P Su; S A Muller
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

Review 5.  A review of Merkel cell carcinoma with emphasis on lymph node disease in the absence of a primary site.

Authors:  J A Straka; M B Straka
Journal:  Am J Otolaryngol       Date:  1997 Jan-Feb       Impact factor: 1.808

Review 6.  Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management.

Authors:  Michael J Veness
Journal:  Australas J Dermatol       Date:  2006-08       Impact factor: 2.875

7.  Neuroendocrine carcinoma within lymph nodes in the absence of a primary tumor, with special reference to Merkel cell carcinoma.

Authors:  V Eusebi; C Capella; A Cossu; J Rosai
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

Review 8.  Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment.

Authors:  C L Hitchcock; K I Bland; R G Laney; D Franzini; B Harris; E M Copeland
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

9.  Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases.

Authors:  Deborah Pan; Deepak Narayan; Stephan Ariyan
Journal:  Plast Reconstr Surg       Date:  2002-10       Impact factor: 4.730

10.  Mixed Merkel cell carcinoma and squamous cell carcinoma of the skin.

Authors:  M V Iacocca; J L Abernethy; C M Stefanato; A E Allan; J Bhawan
Journal:  J Am Acad Dermatol       Date:  1998-11       Impact factor: 11.527

View more
  4 in total

1.  Poorly differentiated neuroendocrine carcinoma in a perigastric lymph node from an unknown primary site.

Authors:  Hee Seung Lee; Hye-Suk Han; Sung-Nam Lim; Hyun-Jung Jeon; Ho-Chang Lee; Ok-Jun Lee; Hyo Young Yun; Ki Hyeong Lee; Seung Taik Kim
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

2.  Primary merkel cell carcinoma clinically presenting as deep oedematous mass of the groin.

Authors:  T Gambichler; S Kobus; A Kreuter; U Wieland; M Stücker
Journal:  Eur J Med Res       Date:  2010-06-28       Impact factor: 2.175

3.  Merkel cell carcinoma of the retroperitoneum with no identifiable primary site.

Authors:  Daniele Rossini; Salvatore Caponnetto; Vittoria Lapadula; Lucilla De Filippis; Gabriella Del Bene; Alessandra Emiliani; Flavia Longo
Journal:  Case Rep Oncol Med       Date:  2013-09-01

4.  Primary retroperitoneal Merkel cell carcinoma: Case report and literature review.

Authors:  Osvaldo A Quiroz-Sandoval; Mario Cuellar-Hubbe; Leonardo S Lino-Silva; Rosa A Salcedo-Hernández; Horacio N López-Basave; Alejandro E Padilla-Rosciano; Alberto M León-Takahashi; Ángel Herrera-Gómez
Journal:  Int J Surg Case Rep       Date:  2015-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.